[
Home
] [
Archive
]
Main Menu
Home
Journal Information
Editorial Board
Aims& Scopes
Journal News
About the Journal
Articles archive
All Issues
Current Issue
For Authors
Call for Papers
Submission Instruction
Submission Form
Submission Checklist
For Reviewers
Reviewers Section
Registration
Registration Information
Registration Form
Contact us
Contact Information
Contact us
Site Facilities
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
Medical Journalism
Publication Ethics
Search in website
Search the articles
Search the site
Advanced Search
INDEX
Volume 12, Issue 2 (12-2018)
Iran J Virol 2018, 12(2): 38-40
Back to browse issues page
The MiR-29 Family as Novel Therapeutic Option for Retroviral Infection
Masoud Keikha
,
Mohsen Karbalaei
*
Department of Microbiology and Virology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
Abstract:
(2762 Views)
This article has no abstract.
Full-Text
[PDF 364 kb]
(1520 Downloads)
Type of Study:
Letter to editor
|
Subject:
General
Received: 2019/04/18 | Accepted: 2019/11/27 | Published: 2019/11/27
Send email to the article author
Add your comments about this article
Your username or Email:
Download citation:
BibTeX
|
RIS
|
EndNote
|
Medlars
|
ProCite
|
Reference Manager
|
RefWorks
Send citation to:
Mendeley
Zotero
RefWorks
Keikha M, Karbalaei M. The MiR-29 Family as Novel Therapeutic Option for Retroviral Infection. Iran J Virol 2018; 12 (2) :38-40
URL:
http://journal.isv.org.ir/article-1-350-en.html
Rights and permissions
This work is licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License
.
Volume 12, Issue 2 (12-2018)
Back to browse issues page
Persian site map -
English site map
- Created in 0.05 seconds with 38 queries by YEKTAWEB 4660